-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tobemstomig in Metastatic Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tobemstomig in Metastatic Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tobemstomig in Metastatic Renal Cell Carcinoma Drug Details: RG-6139...
-
Product Insights
Alopecia Areata – Drugs In Development, 2023
Global Markets Direct’s, ‘Alopecia Areata - Drugs In Development, 2023’, provides an overview of the Alopecia Areata pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alopecia Areata, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Alopecia - Drugs In Development, 2023’, provides an overview of the Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Influenza [Strain A/H7N9] Vaccine in Influenza A Virus, H7N9 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza [Strain A/H7N9] Vaccine in Influenza A Virus, H7N9 Subtype Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Influenza [Strain A/H7N9] Vaccine in Influenza...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC) Drug Details:Adagloxad simolenin...
-
Company Profile
Netmarble Corp – Company Profile
Netmarble Corp (Netmarble) is a mobile gaming company. It carries out developing various games including Assault Gear, Blossom Party, BTS WORLD, Destiny6, Disney Magical Dice, District 187: Sin Streets, Dragon Ball Online, Dragon Striker, Everybody's Marble, Firstborn: Kingdom Come, Fishing Strike, Grandchase, GunZ: The Duel, Iron Throne, and others. The company's games are supported in android, apple, and others. It's games are used across various regions including the Americas, Europe, Asia-Pacific, Middle East, and Africa. Netmarble is headquartered in Seoul,...
Add to Basket -
Company Profile
Aristocrat Leisure Ltd – Company Profile
Aristocrat Leisure Ltd (Aristocrat) develops and distributes diversified products and services including class II and class III gaming machines and casino management systems. The company’s gaming portfolio includes RAID, Vikings, Dragon Link, Game of Thrones, Wonder 4, Dollar Storm: Buffalo Gold Revolution, Grand Star: Zorro, Timber Wolf Diamond: Cashman bingo, Choy’s Kingdom, Gold Stacks 88, The Hunt for Neptine Gold, and Lightning link. It also manufactures electronic gaming machines, social gaming and casino management systems. The company operates in online...
Add to Basket -
Company Profile
CD Projekt RED SA – Company Profile
CD Projekt RED SA (CD Projekt) is a designer, developer and publisher of role-playing video games. The product portfolio of the company includes the witcher; the witcher 2: assassins of Kings; the witcher 3: wild hunt, cyberpunk 2077, throne-breaker, the witcher tales, the witcher adventure game, went, the witcher card game. ICD Projekt also develops online multiplayer games and distributes digital video games through a wide range of online channels and digital distribution platforms directly to individual users across Russia,...
Add to Basket